WASHINGTON — By now we've all heard that the Pfizer COVID-19 vaccine has an efficacy rate of 95%, Moderna of 94%, and Johnson & Johnson about 66%; what you may not have known is that rate's technical ...
IN THIS issue of the Journal of Clinical Oncology, Chao et al 1 report the results of a study that examined the impact of using four different risk/benefit measures when communicating survival ...
GLP-1 drugs are 36% more effective than aspirin in reducing colorectal cancer risk, with fewer side effects like acute kidney ...
INGELHEIM, Germany and INDIANAPOLIS--(BUSINESS WIRE)--Full results from the EMPEROR-Reduced Phase III trial in adults with heart failure with reduced ejection fraction, with and without diabetes, ...
O’Brien et al. report that the combination of casirivimab and imdevimab (REGEN-COV) reduced the risk of symptomatic Covid-19 by 81.4% among persons exposed to SARS-CoV-2. 1 However, we question the ...
Researchers provided comprehensive evidence of the benefits of statin use in elderly patients, addressing longstanding uncertainties. The robust evidence demonstrated that continuous statin therapy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback